MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Strategic Growth
TERUMO CORP UNSP/ADR (TRUMY)
NASDAQ:AMEX Investor Relations:
terumo.com/investor/library/index.html
Company Research
Source: Business Wire
ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.Founded in 1997 and acquired by Terumo Corporation in 2006, MicroVention has been at the forefront of developing technologies that support neurovascular surgeons in preserving and restoring brain health. As Terumo Neuro, the company is poised to continue its legacy of innovation with an enhanced focus on driving impactful growth and leveraging Terumo’s global resources and reputation.Carsten Schroeder, President and CEO of Terumo Neuro, commented on the rebranding: "This transformation reflects our growth as a company and Terumo's confidence in our fut
Show less
Read more
Impact Snapshot
Event Time:
TRUMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRUMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRUMY alerts
High impacting TERUMO CORP UNSP/ADR news events
Weekly update
A roundup of the hottest topics
TRUMY
News
- Patients, Scientists Agree: Automated Red Blood Cell Exchange Enhances Quality of Life in Sickle Cell Disease PatientsPR Newswire
- Terumo Corporation (TRUMF) Q2 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- NAMSA and TERUMO Announce Strategic Outsourcing PartnershipBusiness Wire
- Terumo (TRUMY) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]Yahoo! Finance
- Here's Why Momentum in Terumo (TRUMY) Should Keep going [Yahoo! Finance]Yahoo! Finance